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CCR8 Expression Defines Tissue-Resident Memory T Cells in
Human Skin
Michelle L. McCully,*,† Kristin Ladell,*,† Robert Andrews,† Rhiannon E. Jones,†,‡
Kelly L. Miners,*,† Laureline Roger,* Duncan M. Baird,†,‡ Mark J. Cameron,x
Zita M. Jessop,{ Iain S. Whitaker,{ Eleri L. Davies,‖ David A. Price,*,† and
Bernhard Moser*,†
Human skin harbors two major T cell compartments of equal size that are distinguished by expression of the chemokine receptor
CCR8. In vitro studies have demonstrated that CCR8 expression is regulated by TCR engagement and the skin tissue microen-
vironment. To extend these observations, we examined the relationship between CCR8+ and CCR82 skin T cells in vivo. Pheno-
typic, functional, and transcriptomic analyses revealed that CCR8+ skin T cells bear all the hallmarks of resident memory T cells,
including homeostatic proliferation in response to IL-7 and IL-15, surface expression of tissue localization (CD103) and retention
(CD69) markers, low levels of inhibitory receptors (programmed cell death protein 1, Tim-3, LAG-3), and a lack of senescence
markers (CD57, killer cell lectin-like receptor subfamily G member 1). In contrast, CCR82 skin T cells are heterogeneous and
comprise variable numbers of exhausted (programmed cell death protein 1+), senescent (CD57+, killer cell lectin-like receptor subfamily
G member 1+), and effector (T-bethi, Eomeshi) T cells. Importantly, conventional and high-throughput sequencing of expressed TCR
b-chain (TRB) gene rearrangements showed that these CCR8-defined populations are clonotypically distinct, suggesting unique ontog-
enies in response to separate antigenic challenges and/or stimulatory conditions. Moreover, CCR8+ and CCR82 skin T cells were
phenotypically stable in vitro and displayed similar levels of telomere erosion, further supporting the likelihood of a nonlinear differ-
entiation pathway. On the basis of these results, we propose that long-lived memory T cells in human skin can be defined by the
expression of CCR8. The Journal of Immunology, 2018, 200: 1639–1650.
I
n steady state, the vast majority of memory T cells reside in
peripheral tissues. These peripheral immune surveillance T (TPS)
cells are long-lived, Ag-experienced sentinels that localize pref-
erentially to sites of high pathogen encounter, such as the lung, gut, and
skin, where they provide a first line defense against recurrent infections
and control aberrant autoimmunity (1). Although originally thought to
be composed entirely of effector memory T (TEM) cells migrating from
the blood, it is now clear that many TPS cells exist in disequilibrium
with the circulating pool (1, 2). As such, the TPS compartment incor-
porates both noncirculating memory T cells that persist in situ, termed
tissue-resident memory T (TRM) cells, as well as memory T cells that
re-enter the circulation and express tissue-specific homing receptors
(3, 4). The mechanisms that regulate effector T cell trafficking during
the onset of an immune response have been studied in isolator-housed
mice, where the tissue T cell compartments are fully defined by the
arrival of new effector T cells induced during local vaccination. Con-
versely, very little is known about the mechanisms that regulate the
homeostatic localization and maintenance of long-lived memory
T cells in peripheral tissues, although the microenvironment has been
shown to direct the transformation of newly recruited effector T cells
into TRM cells (5–7). It is also unclear how tissue-resident and recir-
culating TPS cells are generated and maintained in humans. This is an
important knowledge gap in light of the fact that deregulation of the
TPS network contributes to inflammatory diseases and cancer (8–11).
In contrast to murine skin, where epidermal CD8+CD103+
T cells dominate the TRM pool (2, 3), human skin is inhabited
primarily by dermal CD4+CD1032 T cells (12). At present, CD69
expression remains the principal defining feature of TRM cells
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(12, 13). A recent study found that human CD69+ T cells isolated
from tissues share a core gene signature with mouse TRM cells,
whereas CD692 T cells display features of circulating T cells (14).
As such, the few skin-resident T cells that lack CD69 are thought
to be either central memory T (TCM; CCR7+CD62L+) or migratory
memory T (CCR7+CD62L2) cells (12). In mice, it is clear that
both TRM and TCM cells are derived from the same effector pre-
cursors (10). However, the relationship between these distinct
subsets of memory T cells that constitute the local TPS compart-
ment in human skin requires clarification.
Our previous studies have suggested that the chemokine CCL1
controls the skin-specific localization ofmemory T cells expressing the
chemokine receptor CCR8 (4). In humans, CCR8 is found on a large
proportion of cutaneous memory T cells (∼50%), whereas very few
circulating memory T cells (∼5%), all of which are cutaneous
lymphocyte Ag+ with a TCM or TEM phenotype, express CCR8
(15, 16). CCL1, the selective ligand for CCR8, is primarily expressed
by Langerhans cells and dermal perivascular cells (15). In mice,
CCR8 has been associated with the recruitment of Th2 cells to sites
of atopic dermatitis (17), and CCR8 transcripts are induced in cuta-
neous TRM cells following the resolution of viral infections (18, 19).
However, cell-surface expression of murine CCR8 was not confirmed
in these studies due to a lack of Ab reagents. We showed previously
that naive T cells upregulate CCR8 in the presence of soluble epi-
dermal factors, such as keratinocyte-derived PGE2 and vitamin D3
(16, 20). These findings implicate the tissue microenvironment as a
key regulator of immunological memory in the skin. In this study, we
report that two distinct subsets of TPS cells can be identified in human
skin on the basis of divergent phenotypic, functional, and tran-
scriptomic profiles that cosegregate with the expression of CCR8.
Materials and Methods
Media
Complete AB-RPMImedium consisted of RPMI 1640 supplemented with 2mM
L-glutamine, 1% nonessential amino acids, 1% sodium pyruvate, 50 mg/ml
penicillin/streptomycin, 20 mM HEPES, and 10% pooled human AB serum.
Cell isolation
All research involving human blood and tissue samples was approved by the
local Research Ethics Committee. Written informed consent was obtained
from each participant in accordance with the Declaration of Helsinki.
PBMCs were isolated from healthy donors via density gradient centrifu-
gation using Lymphoprep (Axis-Shield). Human split skin samples
(0.4 mm)were excised from healthy donors undergoing elective surgery using
a dermatome. Sections were cut into 1 cm2 fragments and digested in a
mixture of Dispase II (1.25 U/ml), collagenase D (1 mg/ml), and DNase I
(20 U/ml) (all from Roche) for 15–30 min at 37˚C. The epidermis was
separated from the dermis using forceps, and both the epidermis and the
dermis were subsequently cultured for 48 h at 37˚C in AB-RPMI. Single-cell
suspensions of migrated cells were obtained from the culture medium by
passing through a 40 mm pore mesh, washed, and resuspended in AB-RPMI.
Flow cytometry
Cells were acquired using a custom-built 20 parameter FACSAria II
(BD Biosciences) and analyzed with FlowJo software (Tree Star). The
commercial mAbs used in this study are listed in Supplemental Table I.
Killer cell lectin-like receptor subfamily G member 1 (KLRG1)–AF488
was a kind gift from Prof. H. Pircher (University of Freiburg). Intracellular
staining was performed using a FOXP3/Transcription Factor Staining
Buffer Set (eBioscience). For the detection of cytokines, samples were
depleted of regulatory T (TREG) cells using CD25 microbeads (Miltenyi Bio-
tec) prior to stimulation with PMA (50 ng/ml) and ionomycin (750 ng/ml) for
6 h in the presence of brefeldin A (10 mg/ml) for the final 4 h. Streptavidin-
QD605, streptavidin-BV605, or streptavidin-allophycocyanin (BD Bio-
sciences) were used with biotinylated anti-CCR8 clones 433H or 414B
(American Type Culture Collection) to detect CCR8 expression as reported
previously (17). Lymphocytes were gated based on light scatter, doublets
were excluded in forward scatter area/height plots, and dead cells were
dumped using LIVE/DEAD Fixable Aqua (Thermo Fisher Scientific).
Proliferation assay
Conventional CD252 skin T cells were sorted by flow cytometry, labeled
with CellTrace Violet (Thermo Fisher Scientific) for 10 min at room
temperature, washed, and cultured for 5 d with autologous skin dendritic
cells (DCs) at a ratio of 1:5 (DC/T cell) in the presence of either 50 ng/ml
IL-15 or 50 ng/ml IL-7 + 50 ng/ml IL-15. As a positive control, cells were
stimulated with anti-CD3/CD28 Human T-Activator Dynabeads (Thermo
Fisher Scientific) at a bead/cell ratio of 1:2 in the presence of 30 U/ml IL-2.
Transcriptome analysis
Total RNA was isolated using a Qiagen RNeasy Micro Kit (Qiagen), and
cDNA was generated using a SMARTer Kit (Clontech). Libraries were
prepared using a Nextera Kit (Illumina). Next-generation sequencing was
performed using the Illumina HiSeq 2500 System with TruSeq Technology
(Illumina). Transcriptomes were characterized via paired-end, 50 bp
RNA sequencing (RNA-Seq) runs (10 samples per lane), ensuring at least 303
106 mapped reads per sample. Analysis of gene expression was first evaluated
using TopHat (21) and Cufflinks (22). A paired analysis was then performed,
whereby data were mapped to the human assembly (Homo_sapiens.GRCh38)
using the Burrows–Wheeler Alignment tool (23), and raw read counts per
gene/transcript were assigned using featureCounts (24). Differential gene
expression analysis was performed using the DESeq2 package in Bio-
conductor (25). Gene enrichment analysis was performed using ToppGene
with a false discovery rate correction cutoff of p , 0.05 (26).
Molecular analysis of TCR usage
TCR clonotyping was performed using a template-switch anchored RT-PCR
(27). Amplicons were subcloned, sampled, Sanger sequenced, and ana-
lyzed as described previously (28). Assembly of TCR sequences from
short-read RNA-Seq data was performed using MiXCR software (29), and
postassembly repertoire analysis was performed using VDJTools (30). For
repertoire overlap, similarity was measured as the clonotype-wise sum of






where wik and wjk are the frequencies of clonotype k in samples i and j,
respectively, and N is the total number of overlapping clonotypes.
Single telomere length analysis
DNAwas extracted from 3000 flow-sorted skin T cells using a QIAmpDNA
Micro Kit (Qiagen) (31). Single telomere length analysis was carried out at
the XpYp telomere as described previously (32). Briefly, 1 mM of the
Telorette-2 linker was added to purified genomic DNA in a final volume of
40 ml per sample. Multiple PCRs were performed for each test DNA in
10 ml volumes incorporating 250 pg of DNA and 0.5 mM of the telomere-
adjacent and Teltail primers in 75 mM Tris-HCl (pH 8.8), 20 mM
(NH4)2SO4, 0.01% Tween-20, and 1.5 mM MgCl2, with 0.5 U of a 10:1
mixture of Taq (ABGene) and Pwo polymerase (Roche). DNA fragments
were resolved by 0.5% Tris-acetate-EDTA agarose gel electrophoresis and
identified by Southern hybridization with a random-primed a-33P-labeled
(PerkinElmer) 59-TTAGGG-39 repeat probe, together with probes specific
for the 1 kb (Stratagene) and 2.5 kb (Bio-Rad) markers. Hybridized
fragments were detected using a Typhoon FLA 9500 Phosphorimager
(GE Healthcare). The molecular sizes of the DNA fragments were calcu-
lated using a Phoretix 1D Quantifier (Nonlinear Dynamics).
Statistics
Significance testing was performed using the Mann–Whitney U test, the
Dunn multiple comparison test, one-way ANOVAwith the Tukey posttest,
and linear regression analyses in GraphPad Prism. A difference between
groups was considered significant at p , 0.05. Heatmaps and multi-
dimensional scaling analyses were generated in R.
Accession code for RNA-Seq datasets
The RNA-Seq data reported in this manuscript are available via
ArrayExpress (http://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-
6370) under accession number E-MTAB-6370.
Results
Distribution of CCR8+ cells in healthy human skin
To characterize the expression of CCR8 in healthy human skin, we
separated the dermal and epidermal layers and used flow cytometry
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to analyze the various emigrant cell populations. ab T cells were
the most abundant immune cell type isolated from the dermal
layer (44.15 6 13.62% of total live cells; n = 6) and the pre-
dominant subset to express CCR8 (93.2 6 4.1% of total CCR8+
emigrant skin cells; Fig. 1A) (16). In agreement with our previous
report (33), gd T cells and NK cells were also found to express
CCR8, although these subsets populated the skin at much lower
frequencies (0.35 6 0.25% and 0.97 6 0.56%, respectively) than
ab T cells (Fig. 1B, 1C). Vd1-expressing gd T cells, like ab
T cells, showed more consistent CCR8 expression among donors
(48.73 6 5.92% for ab and 38.61 6 18.54% for d1), whereas the
expression of CCR8 by NK and Vd2-expressing gd T cells was
considerably more variable (Fig. 1B, 1C). CCR8 expression was
not detected on B cells or APCs in either the dermal or epidermal
layers (Fig. 1C). Among ab T cells, CCR8 was expressed by both
the CD4+ and CD8+ subsets in the dermis and epidermis (Fig. 1D,
1E), with a greater percentage of CD4+CCR8+ T cells in both
compartments (59.21 6 13.5% for dermis and 66.62 6 15.77%
for epidermis; n = 10; Fig. 1E). Interestingly, CD4+FOXP3+ TREG
cells, which constituted ∼5–10% of dermal and epidermal CD3+
T cells (Fig. 1D, 1E), almost uniformly expressed CCR8 (76 6
16.3% for dermis and 85.36 2.6% for epidermis; n = 10, Fig. 1E).
We conclude that CCR8 does not distinguish between dermal and
epidermal memory T cells, whereas uniform expression on TREG
cells suggests a role for CCR8 in the cellular control of skin-
specific autoimmunity.
CCR82 skin T cells express genes associated with immune cell
activation
In broad terms, the presence of CCR8+ and CCR82memory T cells
in human skin could reflect either local phenotypic conversion or
independent ontogenies leading to distinct tissue-resident compart-
ments. To investigate the relationship between these subsets, we
performed a whole transcriptome analysis of the CCR8+ and CCR82
fractions sorted in parallel from the conventional CD4+ and CD8+
T cell populations of five healthy skin donors (breast, n = 3; thigh,
n = 2) and three healthy blood donors (Supplemental Fig. 1). For the
purpose of this study, TREG cells (CD25hi) were excluded from the
sorted T cell subsets, and unsupervised data analysis methods were
used to compare the CCR8+ and CCR82 fractions. In a first analysis,
we found that the skin replicates clustered according to tissue sam-
pling site (breast versus thigh) for both CD4+ and CD8+ T cells
(Supplemental Fig. 1A, 1B). Of note, CD8+CCR8+ T cells isolated
from the thigh region displayed an intermediate pattern of expression
for genes that are normally polarized between the skin (e.g., CXCR6
and CD69) and the blood (e.g., KLF2, S1PR1, and CCR10)
(Supplemental Fig. 1C). Although the relevance of this finding is
presently unclear, it is important to document for future studies that
the transcriptomes of skin T cells may vary according to location.
Irrespective of sampling site, we identified 196 differentially
expressed genes (DEGs) when comparing the transcriptomes of
skin CD8+CCR8+ T cells versus skin CD8+CCR82 T cells. Of
these DEGs, 66 were more highly expressed in the CCR8+ frac-
tion, 130 were more highly expressed in the CCR82 fraction, and
13 were uniquely expressed in the CCR82 fraction. Interestingly,
many of the genes upregulated in the CCR82 fraction encode
proteins associated with immune cell activation and effector
function (Fig. 2A). Further enrichment analysis confirmed this
bias within the CD8+CCR82 memory T cell subset (Fig. 2B). The
upregulated genes included those encoding the cytolytic mole-
cules perforin (PRF1) and granzymes (GZMs) A, B, H, and K
(GZMA, GZMB, GZMH, and GZMK), the chemokines CCL3 and
CCL5 (CCL3 and CCL5), the chemokine receptor CXCR3
(CXCR3), the integrins a1 and a4 (ITGA1 and ITGA4), the TNF
family receptor 4-1BB (TNFRSF9), and eomesodermin (EOMES),
a transcription factor that regulates effector function in T cells
(34). Conversely, the CCR8+ fraction was enriched for expres-
sion of LEF1, which encodes a transcription factor involved in the
FIGURE 1. T cells and NK cells in healthy human skin express CCR8. (A) Pie chart showing the contribution of ab, gd, NKT, and NK cells to the total dermal
CCR8+ pool. (B) Representative dot plots showing CCR8 expression for the indicated cell types in two donors (donor 12 [d12] and donor 14 [d14]). (C) Percent
frequencies of ab, gd, NK, B, and APCs among total live dermal (top) and epidermal cells (bottom) expressing CCR8 (n = 4–6). LC, Langerhans cells. (D)
Representative dot plots showing the expression of CCR8 versus FOXP3 for CD4+ and CD8+ dermal T cells. (E) Percent frequencies of CD4+FOXP32 con-
ventional T (TCONV), CD4+FOXP3+ TREG, and CD8+ T cells expressing CCR8 in the dermis (n = 10) or epidermis (n = 4–9). Lines denote the geometric mean.
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generation of memory CD8+ T cells (Fig. 2A) (35), and genes
encoding the TGF-binding protein CD109 (CD109), the IL-7 and
IL-9 receptors (IL-7R and IL-9R), and forkhead box protein K2
(FOXK2). Other noteworthy genes in the CD8+CCR8+ memory
T cell subset included AKT2, SESN3, and INSR, which encode
members of the PKB/Akt signaling pathway, and BCL9, which
encodes the transcriptional WNT/b-catenin cofactor.
The transcriptomes of skin CD4+ T cells were far more variable
among donors and tissue sites than the transcriptomes of skin
CD8+ T cells. However, akin to the CD8+ subset, more immune
response genes were found to be upregulated in the CCR82
fraction when samples from distinct tissue sites were analyzed
independently. The CCR82 fraction from breast skin samples
showed greater expression of CCR2, GNLY, LAG3, and HAVCR2,
which encodes TIM-3, whereas the CCR82 fraction from thigh
skin samples showed greater expression of several immune acti-
vation genes, including CCL5, GZMA, GZMB, CXCR3, and genes
encoding the inhibitory receptors LAG3 (LAG3) and programmed
cell death protein 1 (PD-1) (PDCD1) (Fig. 2C).
Overall, these data reveal that CCR82 T cells in healthy skin
preferentially express genes associated with immune cell activa-
tion and effector function.
CCR82 skin T cells show greater effector capacity
The transcriptional profiles of skin T cells suggest that the CCR82
fraction may be better poised to mount effector responses upon
activation. Accordingly, skin CD8+CCR82 T cells expressed
higher levels of transcripts encoding cytolytic molecules com-
pared with skin CD8+CCR8+ T cells (Fig. 3A). This finding was
validated in flow cytometry experiments, which demonstrated
significantly higher levels of perforin in the CCR82 fraction
(Fig. 3B, 3C). A similar pattern was detected among skin CD4+
T cells at the RNA (Fig. 2C) and protein level (Fig. 3B, 3C),
although the percentage of perforin+ cells was much lower com-
pared with skin CD8+ T cells (Fig. 3C).
To extend these functional comparisons, we measured the in-
tracellular production of effector cytokines in response to a non-
specific activation signal. No effector cytokines were detected
among untreated skin T cells (data not shown). In contrast,
stimulated CCR8+ and CCR82 skin T cells produced a variety of
effector cytokines at largely equivalent frequencies, although
greater proportions of CCR82 T cells in both the CD4+ and CD8+
subsets expressed IFNg (Fig. 3D).
In line with greater effector functionality, we found that CCR82
T cells expressed higher levels of the inflammatory chemokine re-
ceptor CXCR3 at the RNA (Fig. 3E) and protein level (Fig. 3F). In
fact, most skin CD8+CCR82 T cells expressed CXCR3 (.80%),
whereas the CCR8+ fraction was more likely to express CCR4 and/or
CCR6 (Fig. 3E–G). Among CD4+ T cells, CXCR3 expression was
again largely restricted to the CCR82 fraction, whereas.60% of cells
in the CCR8+ fraction coexpressed CCR4 and CCR6 (Fig. 3E–G).
Collectively, these results show that both CCR8+ and CCR82 skin
T cells can produce a full complement of effector cytokines, whereas
cytotoxic potential is more firmly associated with a lack of CCR8.
CCR82 skin T cells show signs of chronic Ag exposure
Local survival signals are required to ensure the long-term resi-
dency of memory T cells in peripheral tissues. IL-7 is produced in
the skin under steady-state conditions and is known to play a key
role in memory T cell homeostasis (36). We therefore assessed
IL-7 receptor expression on skin T cells. The vast majority of
CD4+ and CD8+ T cells expressed the IL-7Ra chain (CD127),
most consistently within the CCR8+ fraction (Fig. 4A). However,
the percentage of CD127+ cells among CD8+CCR82 T cells
varied considerably, and a significant proportion did not express
CD127 (43.3 6 16.6%, p = 0.0079; Fig. 4A). For murine CD8+
FIGURE 2. Transcriptional profiles of CCR8+ and
CCR82 skin T cells. (A) Heatmap of DEGs showing
fold changes of .3 between skin CD8+CCR8+ and
CD8+CCR82 T cells. (B) Gene ontology analysis
showing the top five over-represented biological
processes (false discovery rate ,0.05) for DEGs up-
regulated in CD8+CCR82 versus CD8+CCR8+ T cells
from all skin samples. (C) Genes associated with im-
mune function plotted as Log2 fold change for ex-
pression in CD4+CCR82 versus CD4+CCR8+ T cells
from breast skin samples (top) and thigh skin samples
(bottom).
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T cells, expression of CD127 in conjunction with KLRG1 has
been used to define precursors of long-term memory and TRM
(CD127+KLRG12) or short-lived TEM cells (CD1272KLRG1+)
(18, 37). Our analysis showed that human skin CD8+CCR8+
T cells lacked KLRG1, but uniformly expressed CD127, thereby
resembling long-term memory and TRM cells (Fig. 4B–D). In
contrast, the CCR82 fraction incorporated a mixture of short-lived
TEM cells (CD1272KLRG1+), long-term memory and TRM cells
(CD127+KLRG12), and double-negative memory T cells
(Fig. 4B). The percentage of CCR82 T cells with a short-lived ef-
fector memory precursor phenotype ranged from 11.6–52% within
the CD8+ subset (Fig. 4D). A similar pattern prevailed within the
CD4+ subset, albeit with markedly lower frequencies of KLRG1+
cells (Fig. 4B, 4C). Moreover, CD57 and PD-1, which are associated
FIGURE 3. Effector phenotype and function of CCR82 skin T cells. (A) Gene expression counts for cytolytic molecules among CD8+ T cells from all
skin samples (n = 5). (B) Representative dot plots showing perforin expression for gated CD8+CCR8+ and CD8+CCR82 T cells. (C) Percent frequencies of
perforin+ cells within the indicated subsets of skin T cells plotted for each donor (n = 6). (D) Dermal T cells were stimulated ex vivo and analyzed for
cytokine production by flow cytometry. Percent frequencies of IFNg+, IL-4+, TNF-a+, IL-17a+, and IL-22+ cells among CCR8+ and CCR82 T cells within
the CD8+ (left) and CD4+ subsets (right) plotted as mean 6 SD (n = 2). (E) Gene expression counts for inflammatory chemokine receptors among CD8+
T cells from all skin samples (n = 5). (F) Representative histograms showing the expression of CXCR3, CCR6, and CCR4 among CCR8+ (red) and CCR82
T cells (blue) within the CD4+ (top) and CD8+ subsets (bottom). (G) Pie charts showing the relative distribution of chemokine receptors among the
indicated subsets of skin T cells (n = 6). ****p , 0.0001, **p , 0.01, *p , 0.05.
The Journal of Immunology 1643










with terminal differentiation and exhaustion, respectively (38), were
expressed almost exclusively by CD8+CCR82 T cells (Fig. 4E, 4F)
and, to a lesser extent, by CD4+CCR82 T cells (Fig. 4G).
In peripheral blood, TEM cells have been broadly segregated into
four populations based on the expression of CD27, CD28, and
CD45RA (39). Cells that have undergone differentiation as a
consequence of multiple rounds of division lose expression of the
costimulatory receptors CD27 and CD28 and gain expression of
CD45RA. In this model, early effector memory cells are defined
as CD27+/2CD28+CD45RA2, whereas late effector memory cells
lose CD28 expression (CD282CD45RA2), and terminally dif-
ferentiated effector cells re-express CD45RA (CD282CD45RA+).
The acquisition of KLRG1, CD57, and high perforin/GZM ex-
pression is also associated with progressive differentiation among
peripheral blood CD8+ T cells (40). Despite clear differences in
the expression of CD127, KLRG1, PD-1, and CD57 (Fig. 4), we
found that expression of the terminal differentiation marker
CD45RA in skin CD8+ T cells did not correlate with CCR8 ex-
pression (data not shown). The same was true for CD27 and
CD28, although in some donors, a greater percentage of skin
CD8+CCR82 T cells expressed CD28 (78.5 6 16.6% versus
58.4 6 29% for CCR8+; n = 5). In the CD8+ subset, a greater
percentage of CD282 cells expressed CD45RA, consistent with a
terminally differentiated phenotype, but the loss of CD28 did not
correlate with the loss of CD127 or the acquisition of KLRG1,
CD57, or PD-1 (data not shown). These findings imply either that
the acquisition of markers associated with senescence and/or ex-
haustion is independent of effector memory differentiation in the
skin or that the linear differentiation model described for blood
memory T cells is not applicable to skin memory T cells.
Thus, CCR82 skin T cells show more signs of previous Ag
exposure (CD57+, KLRG1+, and PD-1+) compared with CCR8+
skin T cells, despite a quiescent profile in situ (CD252 and Ki-672;
data not shown).
CCR8+ skin T cells possess greater proliferative capacity
On the basis of our phenotypic and transcriptomic findings, we
hypothesized that CCR8+ skin T cells have a proliferative or
survival advantage over their CCR82 counterparts, especially
within the CD8+ subset. Previous experiments have shown that the
majority of cloned skin T cells express CCR8 at variable but stable
levels (15, 33). We found that CCR82 T cells failed to acquire
CCR8 expression upon in vitro activation, whereas CCR8+ T cells
maintained CCR8 expression during in vitro culture (data not
shown). In further experiments, we assessed the homeostatic
turnover of skin T cells by culturing the flow-sorted CCR8+ and
CCR82 fractions with autologous skin DCs in the presence of
either IL-15 alone or IL-7 + IL-15 (Fig. 5). CCR8+ skin T cells
proliferated more robustly than CCR82 skin T cells in the pres-
ence of IL-15, both in terms of the proliferative index (Figs. 5A, 5B)
FIGURE 4. CCR82 skin T cells express markers associated with chronic Ag exposure. (A) Percent frequencies of CCR8+ and CCR82 T cells expressing
CD127 within the CD4+ and CD8+ subsets plotted for each donor (n = 6). Lines denotes mean 6 SD. (B) Representative dot plots showing CD127 versus
KLRG1 expression among CCR8+ and CCR82 T cells within the CD4+ and CD8+ subsets. (C) Percent frequencies of CCR8+ versus CCR82 T cells
expressing KLRG1 within the CD8+ (left) and CD4+ subsets (right) plotted for each donor (n = 6). (D) Percent frequencies of CCR8+ versus CCR82 T cells
within gated dermal CD8+ T cells expressing a short-lived effector memory precursor (CD1272KLRG1+; unfilled gray) or a long-lived memory precursor
phenotype (CD127+KLRG12; black) plotted as mean 6 SD (n = 6). (E) Representative dot plots showing the expression of CCR8 versus CD57 (top) and
PD-1 (bottom) within gated CD8+ T cells. (F) Percent frequencies of CD8+ T cells expressing CD57 or PD-1 within the gated CCR8+ versus CCR82
fractions plotted for each donor (n = 5–11). (G) Percent frequencies of CD4+ T cells expressing CD57 or PD-1 within the gated CCR8+ versus CCR82
fractions plotted for each donor (n = 5–11). ****p , 0.0001, **p , 0.01, *p , 0.05.
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and fold expansion (Fig. 5C). The addition of IL-7 did not further
enhance the proliferative response of CCR8+ skin T cells, despite
greater expression levels of CD127 compared with CCR82 skin
T cells (Figs. 4A, 5A, 5B). As a control, skin T cells were also
stimulated with anti-CD3/CD28 beads in the presence of IL-2. A
greater number of CD8+CCR8+ T cells divided and expanded under
these conditions relative to CD8+CCR82 T cells (Fig. 5). In con-
trast, no significant differences were observed between CD4+
CCR8+ and CD4+CCR82 T cells, either in terms of the proliferative
index (Fig. 5B) or fold expansion (Fig. 5C). These data suggest that
homeostatic turnover is primarily a feature of CCR8+ skin T cells.
CCR8 identifies mature resident memory T cells
Next, we examined whether these phenotypic and functional dif-
ferences could reflect the activation state or recirculation pattern of
skin T cells. The majority of conventional skin T cells isolated
from the dermis lacked expression of CD25 and Ki-67, but
expressed high levels of the tissue retention marker CD69 (data
not shown and Fig. 6A). Although the percentage of CD69+ skin
T cells was equivalent in the CCR8+ and CCR82 fractions
(Fig. 6B), CCR8+ skin T cells expressed a higher surface density
of CD69 relative to CCR82 T cells (Fig. 6A, 6C). Interestingly,
we also found that a significantly greater percentage of CCR8+
dermal T cells expressed CD103 (Fig. 6A, 6B). In a recent re-
port (12), these two markers were used to characterize the
residency/recirculation potential of peripheral tissue T cells in
humans. Specifically, recirculating memory T cells lacked ex-
pression of CD69, whereas CD103 distinguished two pop-
ulations of TRM cells (CD69+CD103+ and CD69+CD1032).
According to this definition, the vast majority of CCR8+ skin
FIGURE 5. CCR8+ skin T cells possess greater proliferative capacity. The proliferation of flow-sorted CCR8+ and CCR82 skin T cells in response to
coculture with autologous skin DCs in the presence of IL-15 or IL-7 + IL-15, or stimulation with anti-CD3/CD28 beads in the presence of IL-2, was
measured using flow cytometry to quantify the dilution of CellTrace Violet. (A and B) Representative histograms and the total number of proliferated cells
for each generation of CD8+ (A) and CD4+ T cells (B). Untreated cells are denoted by gray histograms, and the proliferative index for each cell fraction is
noted. (C) Fold expansion for CCR8+ and CCR82 T cells within the CD8+ (left) and CD4+ subsets (right) plotted as mean 6 SD (n = 2).
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T cells fell within the TRM compartment, and CCR8+CD69+
CD103+ TRM cells were more prevalent than CCR8+CD69+
CD1032 TRM cells (Fig. 6D).
In mice, the lymph node homing receptor CCR7 is essential for
the emigration of tissue T cells (41, 42). Our studies revealed that
only a minority of human skin T cells express CCR7. Among the
subsets defined by CD69 and CD103, non-TRM cells (CD692
CD1032) were the least abundant and contained the highest
proportion of CCR7+ cells (Fig. 6D, 6E). Conversely, CD103+
TRM cells expressed the highest levels of CCR8 and the lowest
levels of CCR7 (Fig. 6D, 6E).
The differentiation of murine skin CD8+ TRM cells depends on
downregulation of the T-box transcription factors T-bet and
eomesodermin (43). In agreement with our transcriptomic data
(Fig. 2A), we found that the expression of T-bet and eomesodermin
correlated inversely with the expression of CCR8, displaying
maximal levels among CCR82CD1272 cells within both the CD4+
and CD8+ T cell subsets (Fig. 6F, 6G).
Collectively, these data indicate that human CCR8+ skin T cells
resemble mouse TRM cells, with a CD69+CD103+ phenotype
lacking CCR7 and showing marked downregulation of T-bet and
eomesodermin.
The CCR8+ and CCR82 fractions of skin T cells are largely
unrelated
As CCR8+ skin T cells resemble bona fide TRM cells and CCR82
skin T cells resemble effector T cells, we next asked whether
CCR8+ T cells could differentiate into CCR82 T cells following
repeated cycles of activation and proliferation. For this purpose,
we used single telomere length analysis (44). Telomere lengths
FIGURE 6. CCR8+ skin T cells are enriched for markers associated with resident memory. (A) Representative histograms showing the expression of
CD69 and CD103 among CCR8+ and CCR82 T cells within the CD4+ and CD8+ subsets. (B) Percent frequencies of CCR8+ and CCR82 T cells expressing
CD69 and CD103 within the CD4+ and CD8+ subsets plotted as a mean 6 SD (n = 6–10). (C) Mean fluorescence intensity (MFI) values for CD69 ex-
pression among CCR8+ and CCR82 T cells within the CD4+ and CD8+ subsets plotted for each donor (n = 6–10). (D and E) Expression of CCR7 and CCR8
among gated CD103+ TRM (CD69+CD103+; white), CD1032 TRM (CD69+CD1032; dotted), and non-TRM cells (CD692CD1032; checked) within the
CD4+ and CD8+ subsets depicted as representative dot plots (D) or shown as mean 6 SD (n = 5) (E). (F) Representative histograms showing the expression
of Eomes (top) and T-bet (bottom) among CCR8+CD127+ (black), CCR82CD127+ (dotted), and CCR82CD1272 (white) dermal CD8+ T cells. (G) Percent
frequencies of Eomeshi and T-bethi cells within the indicated subsets plotted as mean 6 SD (n = 4). **p , 0.01, *p , 0.05.
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within individual cells are defined by the activity of endogenous
telomerase (terminal transferase) and the number of cell divisions,
thereby providing a measure of replicative history. No consistent
differences in telomere length were detected between CCR8+ and
CCR82 skin T cells within either the CD4+ or CD8+ subsets (n = 4;
Fig. 7A), as shown recently for distinct populations of memory
T cells in human peripheral blood (31). Moreover, TERT and TERC,
the genes encoding telomerase, were not present on the list of DEGs
(Fig. 2). These data indicate mixed proliferation histories within
each subset of skin T cells, which is inconsistent with the notion of
directional phenotypic interchange between the CCR8+ and CCR82
fractions.
In peripheral blood, virus-specific memory CD8+ T cells often
display heterogeneous phenotypes that correlate with Ag speci-
ficity. To test the idea that CCR8+ and CCR82 skin T cells differ
phenotypically as a consequence of Ag exposure rather than dif-
ferentiation status, we conducted an unbiased molecular analysis
of expressed TRB gene rearrangements in each subset using a
template-switch anchored RT-PCR (45). Irrespective of CCR8
expression, skin T cells were highly polyclonal, although clono-
typic diversity within the CD4+ subset was markedly restricted in
one case (donor 24; Fig. 7B, Supplemental Fig. 2). Among all
three donors tested, only one TCRb amino acid sequence was
shared between the CCR8+ and CCR82 fractions within the CD4+
and CD8+ T cell subsets (donor 26; Fig. 7B). To extend these
findings with greater coverage, we used MiXCR software to as-
semble CDR3b sequences from the RNA-Seq data (29). In line
with our initial analysis, we found that the CCR8+ and CCR82
fractions were polyclonal and displayed similar levels of diversity
within both the CD4+ and CD8+ T cell subsets (Fig. 7B). More-
over, each repertoire was largely distinct (Fig. 7D, Supplemental
Fig. 3). One exception was noted for donor 30, in whom 12 over-
lapping clonotypes were detected among the top 50 unique sequences
within the CD8+ T cell compartment (F2 = 0.37). Such clonotypic
overlap may reflect a phenotypic switch or divergent fates emanating
from a common precursor. However, the fact that very few TCRb
sequences were shared among the different skin T cell populations
within donors suggests that the CCR8+ and CCR82 fractions arise
predominantly from distinct immune activation events.
Discussion
TPS cells in healthy human skin are composed of two memory ab
T cell compartments distinguished by CCR8 expression (15, 16).
In this study, we report that CCR8+ skin T cells share many fea-
tures of mature TRM cells, including uniform expression of CD69
with low to undetectable levels of the tissue egress receptor
sphingosine-1-phosphate receptor 1 and the lymph node homing
chemokine receptor CCR7. In common with TRM cells in mouse
skin (43), the T-box transcriptional regulators T-bet and eomeso-
dermin (Eomes) were also downregulated, both at the RNA and
protein levels. RNA-Seq analyses revealed significantly elevated
expression of LEF1 in CD8+CCR8+ T cells (35), and a similar trend
was observed for transcripts encoding Hobit (fold change = 2.6)
(35, 46). Moreover, human CCR8+ skin T cells proliferated robustly
in the presence of IL-15 and expanded in response to TCR stimu-
lation. On the basis of these findings, we conclude that CCR8+
memory T cells are likely to persist long-term in healthy human
skin. Of note, murine skin memory T cells also express CCR8
transcripts in response to viral infections (18, 19).
The physiological relevance of CCR8 expression is presently
unclear, but it may be important for TRM cell localization to areas
of chemokine production in skin tissue. CCL1, the selective ligand
for CCR8, is preferentially expressed in human skin, providing
support for the notion of a tissue-specific chemokine system (15).
The finding that stimulated CCR8+ skin T cells produce a large
variety of cytokines is also more compatible with a tissue-defined
rather than a T cell effector type-specific homing program, as has
been described for blood memory CD4+ T cells (47). Moreover,
human skin provides essential cofactors for the induction of CCR8
(16). In particular, active vitamin D3 and PGE2 in combination
with TCR signaling induce robust CCR8 expression in naive
T cells during in vitro culture, suggesting that adaptive cellular
immunity in the skin is governed by Ag encounter and the tissue
microenvironment (20).
Unexpectedly, we found that CCR82 skin T cells were phe-
notypically more diverse than CCR8+ skin T cells and functionally
akin to effector T cells. Of particular note, we detected large
numbers of short-lived effector memory precursor-like cells
(CD127loKLRG-1+) within the CD8+CCR82 subset (37). Many of
these cells also expressed inhibitory receptors (PD-1, Tim-3, and
LAG-3) and/or markers of terminal differentiation/senescence
(CD57 and KLRG1) (38). In contrast, CD8+CCR8+ T cells
expressed low levels of inhibitory receptors, CD57, and KLRG1,
and uniformly expressed CD127. The CCR82 pool was further
enriched for expression of the inflammatory chemokine receptors
CXCR3, CCR2, and CCR5, and higher frequencies of CCR82
skin T cells produced effector cytokines in response to stimulation
compared with CCR8+ skin T cells, potentially reflecting greater
expression of the T-box transcription factors T-bet and Eomes and
relatively low level expression of LEF1 (34, 35). Not surprisingly,
the CCR82 fraction of skin CD8+ T cells was also enriched for
expression of cytolytic molecules as well as integrin a1 (CD49a),
consistent with a recent report (48). Moreover, CCR82 skin
T cells showed defective proliferation and survival relative to
CCR8+ skin T cells in response to homeostatic cytokines or
triggering via the TCR. In sum, these data reveal a striking degree
of heterogeneity among CCR82 skin T cells, many of which
display an end-stage effector phenotype, in contrast to the uniform
memory characteristics of CCR8+ skin T cells.
On the basis of these striking phenotypic and functional dif-
ferences, we hypothesized that the CCR82 effector cell fraction
derives from the CCR8+ memory fraction in response to local
reactivation and/or differentiation. However, we detected no
significant differences between the CCR8-defined subsets with
respect to telomere length, telomerase gene transcription, or the
expression of CD27, CD28, and CD45RA. Moreover, CCR8+
skin T cells retained CCR8 during in vitro culture, whereas
CCR82 skin T cells failed to upregulate CCR8 in response to ex
vivo stimulation (data not shown), even in the presence of
epidermis-conditioned medium (16). A linear relationship be-
tween these two compartments therefore seems unlikely, the data
instead suggesting a stable memory phenotype in human skin
defined by the expression of CCR8.
A recent vaccination study in humans indicated that a single
naive precursor can give rise to functionally diverse effector T cells
with shared Ag specificity (49). It has also been shown that distinct
memory T cell compartments (TRM and TCM) can be generated in
response to challenge with several experimental Ags in a mouse
model of cutaneous vaccination (10). Similarly, two phenotypi-
cally distinct pools of TRM cells with shared pathogen specificity
can be generated in the mouse gut and salivary glands (50, 51). In
contrast to these studies, our molecular analysis of expressed TRB
gene rearrangements revealed profound discrepancies between the
CCR8-defined compartments, suggesting that CCR8+ and CCR82
skin T cells recognize distinct Ags. Of note, several overlapping
clonotypes were detected in one donor, but the degree of com-
monality was minimal compared with that reported for experi-
mentally induced mouse skin TRM and blood TCM cells (10).
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Instead, our findings are reminiscent of another study in which
human skin TREG cells and peripheral blood TCM cells were found to
be clonotypically distinct, thereby suggesting that Ag-driven differ-
entiation of tissue TREG cells does not concomitantly induce circu-
lating memory T cells with corresponding specificities (52).
In humans, a population of CD1032 TRM cells with high levels
of cytolytic activity and inhibitory receptor expression has re-
cently been identified in the lung, although the origin of these cells
is presently unclear (53). There is substantial evidence from
mouse vaccination studies that TRM cells develop locally from
effector cells activated in tissue-draining secondary lymphoid
tissues (2). Moreover, it is known that the tissue microenvironment
instructs effector T cell homing and plays an important role in
promoting TRM differentiation (6, 54). As a consequence, vaccines
should be administered directly at the site of vulnerability to elicit
long-lasting immune protection. Interestingly, certain routes of
vaccination generate effector T cell populations with broader
tissue-homing capabilities, enabling them to enter peripheral tis-
sues that are unrelated to the original site of vaccination (55). In
support of this notion, a recent study in mice revealed that distal
FIGURE 7. CCR8 marks distinct pools of Ag-specific memory T cells. (A) XpYp telomere length distributions for individual cells among the indicated
subsets plotted with mean 6 95% confidence intervals. (B) Unique TCRb amino acid sequences among CCR8+ (x-axis; diamond) and CCR82 skin T cells
(y-axis; open circles) within the CD4+ and CD8+ subsets plotted according to frequency with the total number of sequences denoted in brackets for each
population. Shared sequences are depicted as filled circles with numbers in bold (n = 3). (C and D) TCRb sequences were assembled from RNA-Seq reads
using MiXCR. The estimated diversity index for each subset is plotted for each donor (n = 3) in (C), and the top 50 unique sequences are plotted in (D) as
outlined in (B). ****p , 0.0001, **p , 0.01, *p , 0.05.
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vaccination induced a CXCR3hi TRM cell population in the lung,
whereas local intranasal challenge promoted the differentiation of
a more protective CXCR3lo TRM cell population (56). The route of
immunization therefore impacts on the quality of memory T cells
that become lodged in the target organ, further underscoring the
importance of the tissue microenvironment and draining lymph
nodes in the generation of local protective immunity.
Collectively, the experimental data reported thus far support
the view that TRM cells develop from recruited effector T cells. In
contrast, our results indicate the presence of a more complex
memory T cell compartment in healthy human skin. As naive
T cells require a TCR-mediated signal in the presence of skin-
derived soluble factors to upregulate CCR8 (16, 20), we propose
that long-lasting immune protection against locally encountered
Ags depends on the induction of skin-resident CCR8+ memory
T cells. Moreover, we suggest that the efficacy of skin-targeted
vaccines may be enhanced by strategies designed to maximize the
in situ induction of Ag-specific T cells expressing CCR8.
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